相关实验视频
Updated: Jun 29, 2025

13:07
One-channel Cell-attached Patch-clamp Recording
Published on: June 9, 2014
24.4K
皮埃佐1通道抑制ILC2s,并调节气道过敏反应的发展
Benjamin P Hurrell1, Stephen Shen1, Xin Li1
1Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
The Journal of experimental medicine
|March 26, 2024
概括
肺部的Piezo1通道限制了由2组先天性淋巴细胞 (ILC2) 驱动的2型炎症. 用Yoda1激活Piezo1,可以通过减少ILC2功能和呼吸道过敏反应来治疗过敏喘.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 机械敏感离子通道,如Piezo1,在机械环境中对免疫细胞反应至关重要.
- 2组先天性淋巴细胞 (ILC2s) 在2型炎症和过敏喘中起着重要作用.
- 皮埃佐1在调节肺部ILC2功能中的确切作用尚不清楚.
研究的目的:
- 研究Piezo1通道在调节ILC2s和肺部2型炎症中的作用.
- 在过敏性喘模型中探索Piezo1激活的治疗潜力.
主要方法:
- 在肺部ILC2s中Piezo1的遗传切除.
- 在体外和体内使用Piezo1激动剂Yoda1进行治疗.
- 评估ILC2功能,细胞因子分泌,增殖和氧化代谢.
- 在过敏性喘的小鼠模型中评估气道过敏反应 (AHR).
- 对人类循环中的ILC2s和Yoda1治疗在人性化小鼠中的分析.
主要成果:
- 在ILC2中Piezo1的遗传删除增强了它们的功能,并加剧了AHR.
- Yoda1 治疗抑制了依赖 KLF2.2 的 ILC2 细胞因子分泌和扩散.
- 皮埃佐1的激活减少了ILC2的氧化代谢.
- 在实验性喘模型中,体内Yoda1治疗改善了AHR.
- 人类ILC2s在激活时表达并诱导Piezo1; Yoda1在小鼠中减少了人类ILC2驱动的AHR.
结论:
- 皮埃佐1通道作为ILC2驱动的肺部2型炎症的负调节者.
- 通过Yoda1激活Piezo1,证明了治疗ILC2媒介过敏喘的治疗潜力.
- 准Piezo1为管理过敏呼吸道疾病提供了一种新的策略.
相关概念视频
Mechanically-gated Ion Channels
6.4K
Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
6.4K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K

